N'-(3,4-dimethoxybenzyl)-N,N-dimethylpropane-1,3-diamine, 100mg

7-Bromo-2-methyl-2,3-dihydropyrazolo[5,1-b]oxazole, 97%, 1g

(+)-Pinoresinol>98.0%(GC)25mg

2-(4-Methoxy-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

Formohydrazide>97.0%(HPLC)100g

(4-Methylpent-1-en-1-yl)boronic acid, 95.0%, 100mg

CDTA, min. 99%, for synthesis, 250 g, plastic packaging.

GC capillary column ROTI®Cap-1, 25 m, 0.32 mm, 0.25 µm, 1 Piece(s)

1-Bromo-8-methylnaphthalene, 97%, 250mg

1-Methoxy-5-methylphenazin-5-ium methyl sulfate, 95.0%, 100mg

DL-Lactic Acid>85.0%(T)25g

4,5,6,7-tetrahydroisobenzofuran-1-carboxylic acid, 95.0%, 500mg

5-Chloro-1-methyl-1H-pyrazole-4-carbonitrile, 95.0%, 250mg